MTIP
VYNT

Magee Thomson Investment Partners’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Magee Thomson Investment Partners’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3
Closed -$4K – 170
2014
Q3 		$4K Hold
3
– – ﹤0.01% 135
2014
Q2 		$6K Hold
3
– – ﹤0.01% 120
2014
Q1 		$8K Hold
3
– – ﹤0.01% 113
2013
Q4 		$6K Sell
3
-1
-25% -$2.16K ﹤0.01% 128
2013
Q3 		$13K Buy
+4
New +$6.85K ﹤0.01% 93

Other funds holding VYNT

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
SIM
SSI Investment Management Los Angeles, California $1.45B AUM 5.8% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $223M AUM 17.15% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Magee Thomson Investment Partners's VYNT Position: Q4 2014 in Review

Magee Thomson Investment Partners sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2014, closing a stake of 3 shares — an estimated $4K sold.

Magee Thomson Investment Partners first reported a position in VYNT in Q3 2013 and held it in 5 quarters. The position peaked at $13K in Q3 2013. 31 funds tracked by Wall St. Rank hold VYNT as of Q4 2014.

  • Magee Thomson Investment Partners reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Magee Thomson Investment Partners sold 3 Vyant Bio, Inc. Common Stock shares in Q4 2014, an estimated $4K.
  • Magee Thomson Investment Partners first reported a position in Vyant Bio, Inc. Common Stock in Q3 2013 and held it in 5 quarters.
  • Magee Thomson Investment Partners's Vyant Bio, Inc. Common Stock position peaked at $13K in Q3 2013.
  • 31 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2014.

Based on Magee Thomson Investment Partners's 13F filing for Q4 2014, filed 15 Jan 2015.